Trinity Meds GLP-1 Program 2026: Compounded Semaglutide From $159, Tirzepatide Pricing, Process, and What to Verify

ALPHARETTA, Ga., March 10, 2026 (Newswire.com) - Disclaimer: This article is for informational purposes only and does not constitute medical advice. Weight management concerns should be evaluated by qualified healthcare professionals. Always consult a qualified healthcare professional before starting any prescription treatment. This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented.

Trinity Meds GLP-1: 2026 Consumer Guide to Compounded Semaglutide Telehealth Access, Pricing Structure, and What Patients Should Verify

If you have been researching compounded GLP-1 medications for weight management heading into 2026, you have probably come across Trinity Meds. It is one of several telehealth platforms marketing access in this category. The platform offers compounded semaglutide and tirzepatide through an online consultation and home delivery model, with self-pay pricing that starts below the brand-name Ozempic price listed on the company's own website.

Before going any further, there is a distinction every consumer needs to understand clearly: compounded semaglutide and tirzepatide are not FDA-approved finished products. Compounded semaglutide contains semaglutide, but it is not the FDA-approved finished product Wegovy or Ozempic. Compounded tirzepatide contains tirzepatide, but it is not the FDA-approved finished product Mounjaro or Zepbound. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality before they are dispensed. They are prepared by licensed pharmacies under federal and state compounding rules, based on individual prescriptions written by licensed clinicians.

That distinction matters - and it should inform how you evaluate any compounded GLP-1 platform, including Trinity Meds. With that established, this guide walks through how the platform works, what it costs, how it is structured, and what you should verify before proceeding.

View current Trinity Meds program details and pricing

How Trinity Meds Is Structured: Three Entities Explained

Understanding how telehealth GLP-1 platforms are organized is one of the first things worth looking into. Trinity Meds operates through a three-entity structure that is common across the telehealth industry. Each entity serves a distinct role, and understanding that separation helps you know exactly who is responsible for what.

Trinity Meds (Trinity Healthcare Supply, LLC / CareGLP) functions as the telehealth platform - it handles patient coordination, customer support, and the technology that connects everything. According to the company's own terms, Trinity Meds does not directly provide medical or pharmacy services, and payment does not guarantee the writing or dispensing of a prescription. The platform coordinates the process but does not manufacture, dispense, or control the formulation of any medications prescribed as part of these services.

Licensed Medical Providers are independent healthcare professionals who review your health information and determine whether a prescription is appropriate. According to the company's published materials, medical services are provided through independent licensed providers associated with CareValidate Health, CareGLP Affiliated P.C.s, Usable Health, PC, and related affiliated professional entities. These clinicians make prescribing decisions based on their independent professional judgment. Trinity Meds cannot guarantee that any individual will receive a prescription - that determination rests entirely with the evaluating clinician.

Partner Pharmacies compound and dispense the medications based on prescriptions written by those independent providers. According to Trinity Meds, partner pharmacies include Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx.

Why does this matter to you? Because when you see a claim about prescriptions, treatment suitability, or dosing, the decision-maker is always the licensed clinician - not the platform. And when you think about medication quality and preparation, that responsibility sits with the pharmacy - not the platform. Understanding this helps you ask the right questions before enrolling.

It is also worth noting that the company's terms state the online assessment does not itself create a doctor-patient relationship between you and Trinity Meds.

What GLP-1 Medications Does Trinity Meds List?

According to the company's website, Trinity Meds currently lists three medication pathways:

Compounded Semaglutide - According to the company, pricing starts at approximately $159 per month as of March 2026. Compounded semaglutide contains semaglutide, but it is not the FDA-approved finished product Wegovy or Ozempic. It is administered as a once-weekly injection. The compounded product is prepared under different regulatory oversight than the brand-name versions and has not undergone the FDA's full review process as a finished product.

Compounded Tirzepatide - According to the company, pricing starts at approximately $259 per month. Compounded tirzepatide contains tirzepatide, but it is not the FDA-approved finished product Mounjaro or Zepbound. It functions as a dual GLP-1/GIP receptor agonist, meaning it targets two metabolic pathways. As with compounded semaglutide, the compounded version is not the FDA-approved finished product and has not undergone the same review process.

Ozempic (Brand-Name) - The company's website also lists brand-name Ozempic with limited supply noted, starting at approximately $999 per month. This is the FDA-approved finished product manufactured by Novo Nordisk.

According to the company, all medications are administered as once-weekly injections, and pricing includes the prescription process, telehealth visits, and free shipping.

What Published Research Says About GLP-1 Therapies

GLP-1 receptor agonists have become one of the most extensively studied classes of medications in recent years. Understanding what the research shows can help you have a more informed conversation with your clinician - but it is important to understand where that research comes from.

Semaglutide Research: Published trials of FDA-approved semaglutide have reported that the medication can reduce appetite by acting on satiety centers in the brain, slow gastric emptying so food stays in the stomach longer, and help regulate blood sugar levels. In clinical trials studying the FDA-approved formulation, participants experienced meaningful average weight-loss outcomes when the medication was combined with reduced-calorie diets and increased physical activity.

Tirzepatide Research: Published trials of FDA-approved tirzepatide have shown it acts as a dual GLP-1/GIP receptor agonist, targeting both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) pathways. A 2025 head-to-head clinical trial comparing FDA-approved tirzepatide to FDA-approved semaglutide for obesity found that tirzepatide produced greater reductions in body weight over 72 weeks.

The critical distinction: All of that data comes from clinical trials of FDA-approved formulations studied under controlled conditions. These data do not establish equivalent outcomes for compounded finished products. Compounded medications are not FDA-approved finished products and have not been independently studied in comparable clinical trials. The decision about whether any compounded GLP-1 medication is appropriate for your specific situation rests with your evaluating clinician.

This is research-level context about FDA-approved formulations. Trinity Meds' compounded products as finished formulations have not been independently clinically studied. These findings do not mean compounded GLP-1 medications replace prescribed treatment with FDA-approved versions. Always discuss with your clinician which option is appropriate for your specific situation.

How the Trinity Meds Process Works

According to the company's website, Trinity Meds uses a three-step process:

Step 1: Online Assessment. According to the company, the process starts with an online assessment described as taking roughly two minutes. It gathers information about your medical history, current medications, weight management goals, and other health factors. The company describes this initial assessment as having no cost. It is worth noting that according to the company's own terms, this assessment does not create a doctor-patient relationship between you and Trinity Meds.

Step 2: Medical Evaluation. After the assessment, a licensed clinician affiliated with CareValidate Health reviews your information. According to the company, many patients may be prescribed after the assessment, though some may need a telehealth consultation. The clinician determines, in their independent professional judgment, whether prescription GLP-1 medication is appropriate for you. Not everyone will qualify. Payment does not guarantee the writing or dispensing of a prescription.

Step 3: Medication Delivery. If a prescription is written, one of Trinity Meds' partner pharmacies compounds the medication and ships it to you. According to the company, the process from assessment to delivery typically takes approximately 1.5 to 3 weeks. The company states shipping is free and tracked.

See current Trinity Meds pricing and program details

Trinity Meds Pricing and Cost Context

Understanding the full cost picture is important when evaluating any GLP-1 program. Here is what the company publishes, along with broader market context.

Compounded Semaglutide: According to the company, starting at approximately $159 per month as of March 2026. The company markets this as the same price at every dose level, with no hidden fees.

Compounded Tirzepatide: According to the company, starting at approximately $259 per month.

Brand-Name Ozempic: According to the company, starting at approximately $999 per month, with limited supply noted on the website.

First-Time Customer Promotion: According to the company's website, a current promotion offers $100 off plus free shipping for new customers. Verify current promotional terms on the official site before enrolling, as promotional offers are subject to change.

For context, brand-name GLP-1 medicines may cost substantially more out of pocket depending on the specific product, pharmacy, and insurance status. Published pricing data shows brand-name options like Wegovy and Ozempic can range from approximately $1,000 to $1,600 or more per month at full retail price. Compounded alternatives from various telehealth platforms generally range from approximately $129 to $399 per month depending on the medication and platform. These ranges are general illustrative examples and are not specific to any particular pharmacy or insurer.

Insurance and Payment: According to the company, insurance is not required. Trinity Meds describes its program as straightforward self-pay care, and the company's terms note that CareGLP-affiliated medical professional entities are not contracted healthcare providers with any health insurance plans. The company states that Buy Now Pay Later plans are available and that HSA and FSA accounts may be accepted. Always confirm benefits directly with your insurer and your specific HSA/FSA plan administrator, as coverage policies vary.

All pricing information mentioned was based on publicly available information at the time of publication (March 2026) and is subject to change without notice. Always verify current pricing and terms on the official Trinity Meds website before enrolling.

Who Should Consider a Compounded GLP-1 Program - And Who Should Not

A Compounded GLP-1 Program May Align With People Who:

Are exploring prescription GLP-1 access without insurance coverage for brand-name options: If you do not have insurance that covers brand-name GLP-1 medications, self-pay compounded programs represent one pathway to prescription access. According to the company, Trinity Meds' compounded semaglutide starts at $159 per month, which is lower than the brand-name Ozempic price listed on the same website.

Prefer a fully online process: The company describes a process that can begin with a short online assessment and potentially result in a prescription without an in-person visit. For people with straightforward health profiles who value convenience, this streamlined approach may be worth evaluating.

Want access to both semaglutide and tirzepatide pathways: Some telehealth platforms offer only one compounded GLP-1 medication. According to the company, Trinity Meds lists both compounded semaglutide and compounded tirzepatide, which gives the evaluating clinician more flexibility when considering your individual health factors.

Value ongoing support throughout treatment: According to the company, the program includes unlimited check-ins and access to messaging with the clinical team. If you prefer a platform that emphasizes ongoing support rather than a one-time prescription, this is worth evaluating.

Other Pathways May Be Preferable For People Who:

Specifically want FDA-approved finished products: If you or your healthcare provider prefer medications that have undergone the full FDA review process for safety, effectiveness, and quality as finished products, compounded alternatives are not the same thing. Brand-name options like Wegovy, Zepbound, Mounjaro, and Ozempic are available through traditional healthcare channels and carry the full FDA approval.

Have complex medical histories requiring in-person evaluation: While telehealth works for many people, individuals with complicated health profiles, multiple medications, or conditions requiring hands-on assessment may benefit from an in-person consultation with an endocrinologist or obesity medicine specialist before starting GLP-1 treatment.

Have insurance coverage for brand-name GLP-1 medications: Because Trinity Meds operates as a self-pay model with out-of-network providers, individuals who have insurance coverage for brand-name GLP-1 medications may find lower out-of-pocket costs through their existing healthcare plan. Check with your insurer before assuming self-pay is your best option.

Questions Worth Asking Yourself

Before choosing any GLP-1 telehealth platform, consider these questions - your answers will help you determine what matters most for your specific situation:

Have I discussed GLP-1 medications with a physician who knows my full medical history?

Do I understand the difference between compounded medications and FDA-approved finished products, and am I comfortable with the regulatory distinction?

Have I checked whether my health insurance covers brand-name GLP-1 medications before exploring self-pay compounded options?

Am I aware of the contraindications for GLP-1 medications, including personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)?

Have I reviewed the platform's refund policy, auto-renewal terms, and cancellation process?

Safety Considerations for GLP-1 Medications

GLP-1 receptor agonists are prescription medications with known risks, contraindications, and side effects that require clinician oversight. The following points are a high-level overview, not a complete list of risks or precautions. Patients should review the medication-specific safety information that accompanies any prescribed product.

Common Side Effects: The most frequently reported side effects of GLP-1 medications in published clinical studies include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These are commonly reported during dose titration periods and often decrease over time as the body adjusts.

Serious Warnings: GLP-1 receptor agonists carry a boxed warning regarding thyroid C-cell tumors observed in animal studies. They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Other serious but less common risks include pancreatitis, gallbladder problems, kidney issues, and hypoglycemia when used with certain other diabetes medications.

Age and Eligibility: According to the company, Trinity Meds' online service is intended for users 18 years and older. Any considerations outside of this age range would need to be specifically determined by a licensed clinician on a case-by-case basis.

Medication Interactions: GLP-1 medications can interact with other drugs, particularly those affected by delayed gastric emptying. If you take oral contraceptives, blood thinners, diabetes medications, or other time-sensitive oral medications, discuss potential interactions with your prescribing clinician before starting treatment.

Stopping Treatment: According to the company's FAQ, if you stop your GLP-1 program, appetite and weight regain are common. This is consistent with published clinical research showing that weight management with GLP-1 medications typically requires ongoing treatment. Many people either taper, maintain, or restart with a clinician-led plan and lifestyle support.

This overview is not exhaustive and does not replace official prescribing information. Always review the full safety information that comes with your prescription and consult your prescriber or pharmacist with any questions. This is not a replacement for prescribed medical treatment for any health condition.

What to Verify Before Proceeding With Trinity Meds

Before starting any GLP-1 telehealth program, taking time to verify the platform's details and current standing is worth the effort. Here is a practical checklist:

Verify current pricing. All pricing discussed in this article was accurate as of March 2026 based on the company's website. Pricing, promotional terms, and plan structures can change. Confirm current details directly on the official website before enrolling.

Verify pharmacy licensing. Trinity Meds lists its partner pharmacies by name with publicly available contact information - Belmar Pharmacy (800-525-9473), Strive Pharmacy (855-405-5993), Epiq Scripts (833-654-3553), and Casa Pharma Rx (877-937-6868). You can independently verify pharmacy licensing through your state's Board of Pharmacy or the National Association of Boards of Pharmacy.

Verify provider credentials. According to the company, its medical network includes licensed clinicians. You can verify individual provider credentials through the relevant state licensing board.

Verify current state availability. The company's marketing FAQ states the platform services all 50 states. However, the company's formal terms of service state that services are available in certain states and advise prospective users to contact customer service for current availability. Before enrolling, confirm that services are currently available in your state.

Review the refund and cancellation policy. According to the company's terms, medical consult fees are not subject to or eligible for a refund, and all sales of prescription products are final. Additionally, the company's financial consent states that all programs are auto-renewing and you must explicitly request to cancel before your payment is processed. Understand these terms fully before purchasing.

Review the telehealth consent. The company provides a telehealth informed consent document that outlines the benefits, risks, and limitations of telehealth-based care. Review this before proceeding.

Understand the compounded-vs-approved distinction. Compounded medications are not FDA-approved finished products. They are not reviewed by the FDA for safety, effectiveness, or quality before dispensing. Make sure you are comfortable with this distinction before enrolling in any compounded GLP-1 program.

Discuss with your own physician. If you have an existing relationship with a primary care physician, endocrinologist, or other specialist, discussing GLP-1 treatment options with them first can help you make a more informed decision about which pathway is appropriate.

Check current Trinity Meds eligibility and program options

Compounded GLP-1 vs FDA-Approved Options: What Patients Should Know

This distinction comes up frequently in GLP-1 research, so it is worth walking through clearly.

FDA-Approved Medications (Wegovy, Ozempic, Mounjaro, Zepbound) are manufactured by their original drug makers and approved through the full FDA review process. The FDA requires that these products demonstrate safety, efficacy, and manufacturing quality before they can be marketed. They come in standardized doses with established clinical trial data supporting their use for specific indications.

Compounded Medications contain the named active ingredient but are prepared by compounding pharmacies under different regulatory oversight. Compounded medications are not individually FDA-approved products. They are not reviewed by the FDA for safety, effectiveness, or quality before they are dispensed. They are prepared under federal and state compounding rules based on individual prescriptions.

The FDA has issued communications addressing risks associated with some compounded GLP-1 products, and the regulatory landscape for compounded medications continues to evolve. In early 2026, the FDA also issued warning letters to certain telehealth companies regarding marketing claims about compounded GLP-1 products. This does not mean all compounded medications or all telehealth platforms are problematic, but it does mean the regulatory environment is active and consumers should stay informed.

The appropriate pathway depends on clinician judgment, patient-specific medical factors, insurance coverage, regulatory status, and out-of-pocket cost. What matters is that you understand the distinction before making a decision.

Realistic Expectations for GLP-1 Weight Management

Setting realistic expectations matters for anyone considering GLP-1 medications, whether brand-name or compounded.

What Published Research Shows: Published trials of FDA-approved GLP-1 medicines have reported meaningful average weight-loss outcomes under study conditions. Those study participants also followed reduced-calorie diets and increased their physical activity. Those data do not establish equivalent outcomes for compounded finished products. According to the company's own website disclosures, Trinity Meds patients typically experience 1 to 2 pounds per week of weight loss after 4 weeks, involving healthy diet and exercise changes - but the company also notes that results vary, fat loss figures shown on the site are not typical, and outcomes depend on starting weight and program adherence.

Timeline Patterns: Trinity Meds does not publish a detailed week-by-week guaranteed timeline. According to the company's FAQ, many people notice appetite changes early, with more visible weight loss typically building over the first 4 to 12 weeks and continuing over months with consistency. Individual experiences vary widely based on starting weight, lifestyle factors, genetic factors, medication adherence, and other variables.

Lifestyle Integration: GLP-1 medications are not standalone solutions. The clinical data supporting their effectiveness was generated in studies where participants also followed reduced-calorie diets and exercise programs. Any GLP-1 program should be considered part of a broader approach that includes dietary and activity modifications.

Long-Term Considerations: Published research indicates that weight management benefits of GLP-1 medications typically require ongoing treatment. Discontinuation is commonly associated with appetite return and weight regain. Discuss long-term treatment plans with your clinician.

The company website includes customer testimonials and patient-experience statements; those statements reflect individual experiences and should not be interpreted as typical or guaranteed outcomes.

Individual results will vary based on factors including age, baseline health condition, starting weight, lifestyle factors, consistency of use, genetic factors, current medications, dietary adherence, physical activity levels, and other individual variables. Results are not guaranteed.

Frequently Asked Questions

Is Trinity Meds a telehealth platform?

Yes. Trinity Meds operates as a telehealth platform - specifically a patient management and coordination service. According to the company's own terms, Trinity Meds does not directly provide medical or pharmacy services. Medical services are provided through independent licensed providers associated with CareValidate Health, CareGLP Affiliated P.C.s, Usable Health, PC, and related affiliated professional entities. Medications are compounded and dispensed by independent licensed pharmacies. Consumers can verify pharmacy licensing through state Boards of Pharmacy and provider credentials through state medical boards.

What is the difference between compounded and FDA-approved GLP-1 medications?

Compounded medications contain the named active ingredient but are not the FDA-approved finished product. They are prepared by licensed pharmacies under federal and state compounding rules and are not reviewed by the FDA for safety, effectiveness, or quality before dispensing. FDA-approved versions like Wegovy, Ozempic, Mounjaro, and Zepbound have undergone the full FDA review process. See the comparison section above for a more detailed breakdown.

Do I need insurance to use Trinity Meds?

According to the company, insurance is not required. Trinity Meds describes its program as self-pay care. The company's terms note that affiliated medical professional entities are not contracted with any health insurance plans. The company states that HSA and FSA accounts may be accepted. Always confirm benefits directly with your plan administrator.

What happens if I am not approved for a prescription?

According to the company's terms, payment does not guarantee the writing or dispensing of a prescription. The prescribing decision rests entirely with the independent licensed clinician who reviews your health information. If the clinician determines GLP-1 medication is not appropriate for your situation, you would not receive a prescription. Review the company's refund policy regarding consultation fees on their website before beginning the process.

What are the cancellation and auto-renewal terms?

According to the company's financial consent terms, all programs are auto-renewing. You must explicitly request to cancel before your payment is processed. The company's terms also state that they cannot accept returns of prescription products for reuse or resale, and all sales are final. Review the full terms directly on the company's website before enrolling.

What pharmacies does Trinity Meds name?

According to the company, partner pharmacies include Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx. Contact information for each is published on the company's FAQ page.

What states does Trinity Meds serve?

The company's marketing FAQ states the platform services all 50 states. However, the company's formal terms of service state that services are available in certain states and territories, and advise prospective users to contact customer service for current availability. Before enrolling, confirm that services are currently available in your state by contacting the company directly.

What should consumers know about the current regulatory environment?

The compounded GLP-1 medication space has been under increased regulatory attention. The FDA has issued communications addressing risks associated with some compounded GLP-1 products, and in early 2026, FDA issued warning letters to certain telehealth companies regarding marketing claims about compounded GLP-1 products. Consumers should review the most current information about any platform's compliance and regulatory standing before proceeding.

Contact Information

For questions before or during the process, according to the company's website, Trinity Meds offers customer support through the following channels:

Email: [email protected]

Phone: 888-988-3705

Additional Support Email: [email protected]

Business Address: Trinity Meds, Inc., 4575 Webb Bridge Road, Suite 4345, Alpharetta, GA 30005

According to the company, the platform offers unlimited messaging and support as part of the program.

View current Trinity Meds program details on the official website

Evaluating Trinity Meds: Considerations for Prospective Patients

What the platform offers: Trinity Meds provides a self-pay telehealth pathway to compounded GLP-1 medications, with compounded semaglutide starting at a lower price point than the brand-name Ozempic listed on the same website. The three-entity structure provides separation between the platform, clinical decision-making, and pharmacy dispensing. According to the company, the program includes ongoing support, free shipping, and pricing described as transparent with no hidden fees. For consumers evaluating self-pay telehealth access, the platform presents one option in this category.

What to weigh carefully: The company's refund policy is restrictive - medical consult fees are not refundable, prescription product sales are final, and programs are auto-renewing. Compounded products have not undergone the FDA's full review process as finished products. The marketing FAQ and formal terms contain conflicting information about state availability. Consumers should verify pharmacy licensing, provider credentials, current pricing, and cancellation terms independently before enrolling.

The regulatory environment: The compounded GLP-1 medication space has been under increased regulatory scrutiny. The FDA has issued communications addressing risks associated with some compounded GLP-1 products, and in early 2026, issued warning letters to certain telehealth companies regarding marketing claims. This does not apply specifically to Trinity Meds, but it reflects the broader regulatory landscape. Consumers should review the most current information about any platform's compliance, quality, and regulatory standing before proceeding with treatment.

Prospective patients should compare pricing, clinician access, pharmacy sourcing, regulatory disclosures, and cancellation terms across platforms before proceeding. Only a licensed clinician can determine whether GLP-1 treatment is appropriate for your specific case.

See the current Trinity Meds program offer

Disclaimers

Content and Medical Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. The descriptions of potential benefits are not guarantees and are not a substitute for an individualized medical evaluation. GLP-1 medications are prescription medications that require evaluation by a licensed clinician. The information provided here does not replace the professional judgment of your healthcare provider.

Professional Medical Disclaimer: This article is educational and does not constitute medical advice. Prescription GLP-1 medications are not a substitute for prescribed medical treatment. If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting any prescription treatment. Do not change, adjust, or discontinue any medications or prescribed treatments without your physician's guidance and approval.

Compounded Medication Notice: Compounded GLP-1 medications available through Trinity Meds are compounded prescription medications prepared by licensed pharmacies based on individual prescriptions. Compounded medications are not reviewed or approved by the FDA as finished products. They are not the same as FDA-approved brand-name medications. They are prepared using active ingredients under federal and state compounding rules based on prescriptions written by licensed clinicians. Compounded semaglutide is not the FDA-approved finished product Wegovy or Ozempic. Compounded tirzepatide is not the FDA-approved finished product Mounjaro or Zepbound.

Results May Vary: Individual results will vary based on factors including age, baseline health condition, starting weight, lifestyle factors, consistency of use, genetic factors, current medications, dietary adherence, physical activity levels, and other individual variables. Results are not guaranteed. According to the company's own disclosures, fat loss results shown on the website are not typical.

FTC Affiliate Disclosure: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy, neutrality, or integrity of the information presented. All descriptions are based on published research and publicly available information.

Pricing Disclaimer: All prices, discounts, and promotional offers mentioned were accurate at the time of publication (March 2026) but are subject to change without notice. Always verify current pricing and terms on the official Trinity Meds website before enrolling.

Publisher Responsibility: The publisher of this article has made every effort to ensure accuracy at the time of publication. We do not accept responsibility for errors, omissions, or outcomes resulting from the use of the information provided. Readers are encouraged to verify all details directly with Trinity Meds and their healthcare provider before making decisions.

Insurance Coverage Note: Many direct-to-consumer prescription products are not covered by traditional insurance plans, but coverage policies vary. Always confirm benefits directly with your insurer. Some HSA/FSA plans may reimburse qualifying expenses; check your specific plan rules.

SOURCE: Trinity Meds

Source: Trinity Meds